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Abstract: In this study, the first complexes of Zn(II) with the N-benzyloxycar-
bonyl-S-alaninato ligand (N-Boc-S-ala) were synthesized. The new complexes 
were characterized by elemental analysis, conductometric measurements, IR, 
1H-NMR, 13C-NMR and 2D-NMR spectroscopy. On the basis of the experi-
mental data, tetrahedral geometry of the Zn(II) complexes was proposed. A 
very good agreement between the NMR and DFT calculated data was obtained. 
Investigation of antimicrobial activity of the newly synthesized complexes was 
also performed. It was established that [Zn(N-Boc-S-ala)2] was selective and 
acts only on Candida albicans. 
Keywords: antimicrobial activity; DFT; N-benzyloxycarbonyl-S-alanine; NMR; 
Zn(II) complexes. 
INTRODUCTION 
It is well known that metal complexes with aromatic amino acids can serve 
as model systems for the study of various interactions in which aromatic amino 
acids residues participate.1–3 In our previous articles, metal complexes contain-
ing aromatic amino acids were described.4–6 As a continuation, new metal com-
plexes with N-benzyloxycarbonyl (N-Boc) protected amino acids were examin-
ed.7 It is interesting to note that the N-benzyloxycarbonyl amino acids and their 
derivates were reported as anti-convulsant, anti-inflammatory and anti-neoplastic 
agents.8–11 N-Protected amino acids have abilities to function as cholecystokinin 
receptor antagonists12 and derivates of N-Boc amino acids also show a good de-
gree of inhibition of the gastric proton pump.13 
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In spite of interesting biological activities, only a few complexes with N-Boc 
amino acids have hitherto been described.14–18 As N-benzyloxycarbonylglycine 
has favorable membrane penetration properties,19,20 neutral complexes of it with 
various metal ions were prepared in a previous study.7 Since in the literature 
there are no data concerning the antimicrobial activities of these compounds, the 
antimicrobial activities of the obtained metal complexes were also determined. It 
was established that among the investigated strains, the Zn(II) and Co(II) com-
plexes were selective, acting only against the fungus Candida albicans. 
The elaboration of new types of antifungal agents is presently a very urgent 
task.21 As a result of this, the aim of this work was to synthesize new neutral 
zinc(II) complexes with the N-benzyloxycarbonyl-S-alaninato ligand (N-Boc-S- 
-ala), with or without bipyridine as an additional ligand, and to investigate and 
compare the antimicrobial activity of the Zn(II) complexes with N-Boc-S-ala and 
N-Boc-gly ligands with mixed complexes containing 2,2’-bipyridine. 
EXPERIMENTAL 
Materials and measurements 
All the employed reagents and solvents were of analytical grade. N-Boc-Glycine, N-Boc-
-S-alanine, 2,2'-bipyridine and the metal salts were obtained from Aldrich and used without 
further purification. Elemental analyses for C, H, N were performed on a Vario III CHNOS 
Elemental analyzer, Elementar Analysensysteme GmbH. The solid state IR spectra (KBr pel-
lets) were performed on a Perkin-Elmer FT-IR 1726X spectrometer. 
The molar conductivity of a methanolic solution of the complexes (c = 10-3 mol dm-3) 
was measured at room temperature on a Jenway-4009 digital conductivity meter. 
The 1H-NMR (200 MHz) spectra were recorded using a Varian Gemini 2000 spectro-
meter at room temperature in DMSO-d6 solution. The 13C-NMR (50.3 MHz) spectra were 
recorded using the same instrument in DMSO-d6 solution. The solvent peak at 39.7 ppm was 
used to calibrate the scale of chemical shifts. 2D-NMR spectra: DQF–COSY, TOCSY (mix-
ing time 40 ms), ROESY (mixing time 80 ms) and {1H-13C}-HSQC, were recorded on a 
Bruker 700 MHz instrument. 
N-Boc-S-Alanine (Scheme 1). 1H-NMR (δ, ppm): 12.3 (1H, bs, H(1)), 7.62 (1H, d, J = 
= 7.4 Hz, H(NH)), 7.36 (5H, m, H (6,6',7,7',8)), 5.03 (2H, s, H(4)), 4.02 (1H, quintet, J = 7.4 Hz, 
H(2)), 1.27 (3H, d, J = 7.4 Hz, H(9)); 13C-NMR (δ, ppm): 174.8 (C1), 156.2 (C3), 137.3 (C5), 
128.7 (C7,C7'), 128.1 (C8), 128.1 (C6,C6'), 65.7 (C4), 49.5 (C2), 17.3 (C9). 
 
Scheme 1. Numbering of the C atoms in N-benzyloxycarbonyl-S-alanine and in 2,2’-bipyridine. 
 ZINC COMPLEXES WITH N-BENZYLOXYCARBONYL-S-ALANINE 817 
Synthesis of [Zn(N-Boc-S-ala)2]1.5H2O (1) 
To a solution of N-benzyloxycarbonyl-S-alanine (0.20 g, 0.90 mmol) in ethanol–water 
(1:1) mixture (5.0 cm3), ZnCl2 (0.060 g, 0.44 mmol) dissolved in a minimal volume of water 
was added. The resulting solution was allowed to reflux for 30 min, with constant stirring. The 
pH value of the obtained system was then adjusted to 6.0 using NaOH solution (0.20 mol dm-3). 
The resulting suspension was stirred for one hour at room temperature. The reaction 
mixture was then filtered and the obtained filtrate left at room temperature. After a few days, 
the obtained white crystals were separated by suction and then air-dried. Yield: 0.90 g (40 %). 
Synthesis of [Zn(N-Boc-S-ala)2(bipy)]2H2O (2) 
To a 50-cm3 flask, containing 0.18 g (0.34 mmol) of [Zn(N-Boc-S-ala)2]1.5H2O in 2.5 
cm3 of acetonitrile, 0.060 g (0.38 mmol) of 2,2’-bipyridine in 2.0 cm3 of acetonitrile was 
added. The obtained suspension was stirred for one hour without heating. The transparent 
reaction mixture was filtered by suction and the filtrate was left at room temperature. After a 
few days, white-yellow crystals were obtained. Yield: 0.19 g (81 %). 
Synthesis of [Zn(N-Boc-gly)2(bipy)]H2O (3) 
To a solution of [Zn(N-Boc-gly)2]7 (0.10 g, 0.21 mmol) dissolved in chloroform (15 cm3), 
0.032 g (0.20 mmol) of 2,2’-bipyridine dissolved in chloroform (2.5 cm3) was added dropwise 
during 60 min with stirring at room temperature. The mixture was then continuously stirred 
for about 120 min. The filtrate was concentrated in a vacuum evaporator and left in a refri-
gerator. White crystals were obtained two days later. Yield: 0.80 g (61 %). 
Density functional method calculation 
The studied compounds 1 and 2 were subjected to geometry optimization using the den-
sity functional theory (DFT) with the Becke three-parameter exchange functional (B3)22 and 
the Lee–Yang–Parr (LYP) correlation functional.23 The DFT method was used as it gives 
good results for all 3d-metal complexes.24-26 These B3LYP calculations were performed with 
the Gaussian03 program.27 Various rotamers of compounds 1 and 2 were computed. As the 
starting point for the calculation, the conformation of the N-Boc residue obtained by the single 
crystal X-ray method was used.15,18 The DFT calculation was performed for several confor-
mations of the N-Boc-S-ala residuals. The conformation search was performed by variation of 
the Zn–O–C–N torsion angles. The geometries of conformers of the complexes were fully op-
timized using the LANL2DZ basis set. The optimized geometry of the most stable conformers 
of complexes 1 and 2 are given in Figs. 1 and 2, respectively. 
 
Fig. 1. Proposed tetrahedral geometry of the [Zn(N-Boc-S-ala)2] complex (1) 
(structure optimized using B3LYP//LANL2DZ). 
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Fig. 2. Proposed tetrahedral geometry of the [Zn(N-Boc-S-ala)2bipy] complex (2) 
(structure optimized using B3LYP//LANL2DZ). 
Microbiological assay 
N-Benzyloxycarbonyl-S-alanine and its Zn(II) complexes were screened for their in vitro 
antifungal activity against Candida albicans (ATCC 24433) and Aspergillus niger and their 
antibacterial activity against: Escherichia coli (ATCC 25922, Gram negative), Staphylococcus 
aureus (ATCC 25923, Gram positive) and Micrococcus lysodeikticus (ATCC 4698, Gram po-
sitive). The antifungal and antibacterial activity of these complexes was determined using the 
minimal inhibitory concentration (MIC) test.28 The MIC test was performed by making serial 
dilutions in the appropriate medium with the investigated substances dissolved in DMSO in a 
predetermined range of concentration (5000–625 μg ml-1). After plating, the bacteria were 
incubated at 37 °C and the growth was observed after 24 h, while fungi were incubated at 27 °C 
and growth was observed after 72 h. The media for the growth of the bacteria and fungi were 
Mueller-Hinton agar and Sabouraud dextrose agar, respectively. The experiments were perfor-
med in triplicate. The control was DMSO. 
RESULTS AND DISCUSSION 
Synthesis 
One of the goals of this work was the synthesis of neutral (because of facili-
tated transport through cell membranes) complexes of zinc(II) ion with the N-ben-
zyloxycarbonyl-S-alaninato ligand with or without 2,2’-bipyridine as an additi-
onal ligand. Compound 1 was obtained by direct synthesis by the reaction of 
ZnCl2 with the N-Boc-S-ala ligand in the mole ratio 1:2. Complex 2 was obtained 
by reaction of compound 1 with 2,2’-bipyridine in the mole ratio 1:1. Compound 
3 was obtained by the reaction of the previously synthesized [Zn(N-Boc-gly)2] 
complex7 with 2,2’-bipyridine. This complex was synthesized to compare the 
antimicrobial activities of the mixed complexes 2 and 3. The values of the molar 
conductivity of the synthesized complexes in methanol (c = 10–3 mol dm–3), i.e., 
M = 49.15, 42.24 and 43.5 –1 cm2 mol–1 for complexes 1, 2 and 3, respect-
tively, confirmed their non-electrolyte type. 
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Analytic and spectroscopic characterization 
[Zn(N-Boc-S-ala)2]1.5H2O (1). Anal. Calcd. for C22H25O9.5N2Zn: C, 
49.22; H, 5.03; N, 5.22. Found: C, 49.40; H, 4.79; N, 5.43. 1H-NMR (δ, ppm): 
3.96 (1H, quintet, J = 7.4 Hz, H(2)), 7.12 (1H, d, J = 7.8 Hz, H(NH)), 5.01 (2H, 
s, H(4)), 7.35 (5H, m, H (6,6’,7,7',8)), 1.25 (3H, d, J = 7.2 Hz, H(9)). 13C-NMR 
(δ, ppm): 178.1 (C1); 155.9 (C3); 137.5 (C5); 128.6 (C7,C7’); 128.6 (C8); 128.0 
(C6,C6’); 65.4 (C4); 50.5 (C2); 18.8 (C9). 
Zn(N-Boc-S-ala)2(bipy)]2H2O (2). Anal. Calcd. for C32H36O10N4Zn: C, 
54.74; H, 5.13; N, 7.98. Found: C, 54.63; H, 5.03; N, 8.14. 1H-NMR (δ, ppm): 
8.75 (2H, d, J = 4.6 Hz, H(6b,6b')), 8.55 (2H, d, J = 8 Hz, H(3b,3b')), 8.16 (2H, t, 
J = 7.6 Hz, H(4b,4b')), 7.65 (2H, t, J = 5.9 Hz, H(5b,5b')), 7.34 (5H, m, H 
(6,6’,7,7',8)), 6.97 (1H, d, J = 7.6 Hz, H(NH)), 4.98 (2H, s, H(4)), 3.89 (1H, 
quintet, J = 7.4 Hz, H(2)), 3.49 (H2O), 1.19 (3H, d, J = 6 Hz, H(9)). 13C-NMR (δ, 
ppm): 177.6 (C1), 155.7 (C3), 151.0 (C2b,2b’), 149.3 (C6b,6b’), 140.0 (C4b,4b’), 
137.5 (C5), 128.5 (C7,C7’), 128.6 (C8), 127.8 (C6,C6’), 126.0 (C5b,5b’), 121.6 
(C3b,3b’), 65.2 (C4), 50.8 (C2), 19.0 (C9). 
[Zn(N-Boc-gly)2(bipy)]H2O (3). Anal. Calcd. for C30H30O9N4Zn: C, 54.93; 
H, 4.58; N, 8.54. Found: C, 54.63; H, 4.52; N, 8.50. 1H-NMR (δ, ppm): 8.68 (2H, 
d, J = 8 Hz, H(6b,6b')), 8.58 (2H, d, J = 4.4 Hz, H(3b,3b’)), 8.19 (2H, t, J = 7.6 Hz, 
H (4b,4b')), 7.68 (2H, t, J = 6.1 Hz, H(5b,5b’)), 7.33 (5H, s, H (6,6’,7,7',8)), 7.13 
(1H, t, J = 5.5 Hz, H(NH)), 4.99 (2H, s, H(4)), 3.51 (2H, d, J = 6 Hz, H(2)). 13C-NMR 
(δ, ppm): 174.8 (C1), 156.5 (C3), 151.0 (C2b,C2b’), 149.3 (C6b,C6b'), 140.3 
(C4b, C4b’), 137.5 (C5), 128.6 (C7,C7’), 128.6 (C8), 127.9 (C6,C6’), 126.2 
(C5b, C5b’), 121.8 (C3b,C3b'), 65.4 (C4), 43.8 (C2). 
IR spectroscopy of complexes 1–3 
On the basis of the differences in the frequencies of the asymmetric and 
symmetric skeletal vibration of the carboxylic group (1600–1350 cm–1 region) in 
free (∆ν = 182 cm–1) and coordinated N-Boc-S-ala it can be concluded that the 
modes of coordination of the carboxylic group in the complexes of zinc(II) with 
N-Boc-S-ala (1 and 2) are different.29 Namely, in the case of complex 1 (∆ν = 
= 146 cm–1), chelate bidentate coordination of the carboxylic group occurs. These 
findings are in agreement with the coordination mode of the carboxylic group in 
the previously described [Zn(N-Boc-gly)2] complex.7 In the case of the mixed 
complex 2 (∆ν= 208 cm–1), monodentate coordination of the carboxylic group 
seems likely, i.e., the introduction of 2,2’-bipyridine into the coordination sphere 
of the metal ion changes the coordination mode of carboxylic group from biden-
tate to monodentate. 
The complexes 1–3 crystallize with 1–2 water molecules. Since in the IR 
spectra of the new compounds, bands that could be assigned to vibration of coor-
dinated water are missing,29 tetrahedral geometry around the Zn(II) ion in all 
complexes was proposed. 
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DFT calculation 
Since all attempts to obtain a single crystal suitable for X-ray crystallo-
graphy failed, DFT calculation was applied to check the hypothesis that the new 
zinc(II) complexes with N-benzyloxycarbonyl-S-alaninato ligands adopt tetrahed-
ral geometry (Figs. 1 and 2). 
Another goal was to determine which geometry of the complex of stoichio-
metric composition [Zn(N-Boc-S-ala)2bipy] (2) is more stable, the tetrahedral one 
with monodentate coordination of the carboxylic groups (as assumed) or the 
octahedral one with bidentate coordination of the carboxylic group. DFT calcu-
lation was performed for several conformations of the N-Boc-S-ala residuals. The 
conformation search was performed by variation of the Zn–O–C–N torsion angle. 
Each starting geometry was allowed to be fully optimized. The DFT calculation 
revealed that the most stable geometry is tetrahedral with monodentate coordi-
nation of carboxylic groups (Fig. 2). The most stable octahedral geometry is 
higher in energy by 2.6877 kJ mol–1 than the most stable tetrahedral geometry. 
The results of the DFT calculations confirmed the assumption based on IR spec-
troscopy that coordination of 2,2’-bipyridine caused a change in the coordination 
mode of the carboxylic groups of the N-Boc-S-ala ligands, from bidentate to mo-
nodentate. Monodentate coordination of N-Boc-S-ala through carboxylate oxygen 
atom is also in accordance with monodentate coordination of N-benzoylalaninato 
and DL-alaninato ligands in mixed Zn(II)-complexes, the structures of which 
were determined by single crystal X-ray analysis.30,31 
In the case of complex 3 (∆ν = 211 cm–1), coordination of 2,2’-bipy causes a 
change in the coordination mode of the carboxylic group from bidentate (in the 
previously synthesized [Zn(N-Boc-gly)2] complex)7 to monodentate. Tetrahedral 
geometry is proposed for this complex, as in the case of complex 2. 
NMR spectroscopy of complexes 1–3 
Assignment of 1H- and 13C-NMR chemical shifts was obtained from analy-
sis of DQF–COSY, TOCSY and {1H-13C}-HSQC spectra. 
In the 1H-NMR spectra of complexes 1–3, a signal assignable to carboxylic 
group protons was absent, indicating that deprotonation of carboxylic group oc-
curred and that coordination through this group took place. 
The complexes 1–3 were also characterized by means of 13C-NMR spectros-
copy. The higher values of the chemical shift of C(1), C(2) and C(9) atom signals 
in complexes 1–3 in comparison with those of the signals in the respective non-
coordinated ligands,7 strongly suggest that coordination through the carboxylate 
groups had occurred. On the other hand, the absence of a change of the chemical 
shift of the carbamate carbon C(3) indicates that the carbamate group does not 
participate in the coordination. The assumption that coordination through nitro-
gen atom does not occur (except in complexes of Pb(II), Cd(II) and Cu(II) with 
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N-sulfonylamino acids) is in accordance with the data concerning the coordi-
nation abilities of other N-acylated amino acids.15,18,32–34 The NMR spectra of 
the 2,2’-bipyridine complexes show that both pyridine nitrogen atoms participate 
in the coordination. 
The most direct evidence for the DFT calculated geometry is the close con-
tacts between the protons seen in the 2D-ROESY spectrum of 2 (Fig. 3). Thus, 
the proton at position 6b of the 2,2’-bipyridine ligand is close in space to the 
methyl protons at position 9 of the N-benzyloxycarbonyl-S-alaninato ligand. The 
data presented in Fig. 3 give a good example of how theoretical and experimental 
data can fit. 
 
Fig. 3. ROESY spectrum of [Zn(N-Boc-S-ala)2bipy] complex (2) exhibits inter-proton close con-
tacts in agreement with the DFT calculated structure. 1H spectral axis is in ppm relative to TMS. 
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Microbiological assay 
The complexes 1–3 and N-benzyloxycarbonyl-S-alanine were screened for 
their in vitro antifungal and antibacterial activity against representative strains. 
The investigated complex 1 was inactive against bacterial and fungal strains, ex-
cept against Candida albicans. The complex was more efficient in suppressing 
the growth of this pathogen than both the ligand and a simple zinc salt. The MIC 
value (625 μg ml–1) was the same as that obtained for the analogue complex with 
the N-Boc-gly ligand.7 The small increase in lipophilicity caused by the introduc-
tion of a methyl group did not change the MIC value. 
Mixed complexes 2 and 3 suppressed the growth of neither C. albicans nor 
of any other investigated strains. These results are in agreement with those of 
recently in vitro performed antimicrobial studies of Cu(II) and Mn(II) complexes 
with 2,2’-bipy, which also did not suppress the growth of clinical isolates of Can-
dida species, although their complexes with 1,10-phenanthroline were extremely 
toxic to the cells.35–37 Although the MIC values for the present complexes were 
higher in comparison to those obtained, for example, for the Ag(I) complex with 
N-acetylglycine,38 complexes of Zn(II) with N-Boc-gly and N-Boc-S-ala ligands 
were selective in suppressing the growth of C. albicans. Only the established se-
lectivity of zinc(II) complexes with N-benzyloxycarbonylamino acids against one 
of the investigated strains may be of interest for further studies on antimicrobial 
activities of similar compounds. 
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И З В О Д  
СИНТЕЗА, NMR И DFT ПРОРАЧУНАВАЊА И ИСПИТИВАЊЕ АНТИМИКРОБНЕ 
АКТИВНОСТИ Zn(II) КОМПЛЕКСА СА N-БЕНЗИЛОКСИКАРБОНИЛ-S-АЛАНИНОМ 
ДРАГАНА M. MИТИЋ1, ЂЕНАНА У. MИОДРАГОВИЋ1, ДУШАН M. СЛАДИЋ1, ЖЕЉКО J. ВИТНИК1, ЗОРАН M. 
MИОДРАГОВИЋ1, KАТАРИНА K. АНЂЕЛКОВИЋ1, MИЛАНКА Ђ. РАДУЛОВИЋ2 и НЕНАД O. ЈУРАНИЋ3 
1Hemijski fakultet, Univerzitet u Beogradu, Studentski trg 12–16, 11001 Beograd, 2Centar za hemiju, 
Institut za hemiju, tehnologiju i metalurgiju, Wego{eva 12, 11000 Beograd i 3Mayo Clinic and Foundation, 
Rochester, 59905 Minnesota, USA 
У овом раду су синтетизовани први комплекси Zn(II) са N-бензилоксикарбонил-S-ала-
нинато лигандом (N-Boc-S-ala). Комплекси су окарактерисани елементалном анализом, кон-
дуктометријским мерењем, IR, 1H-NMR, 13C-NMR и 2D-NMR спектроскопијом. Тетраедар-
ска геометрија Zn(II) комплекса претпостављена је на основу експерименталних података. 
Добијено је веома добро слагање између NMR и DFT података. Испитивана је антимикробна 
активност новосинтетизованих комплекса. Установљено је да je [Zn(N-Boc-S-ala)2] комплекс селективан и да делује само на гљиву Candidа albicans. 
(Примљено 23. јануара, ревидирано 1. априла 2008) 
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